SEC Form 4 · accession 0001683168-19-000530
MEDICINOVA INC · MNOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Masatsune Okajima
Officer — VP and Head of Japanese Office
Period of report
Feb 28, 2019
Accepted (ET)
Mar 4, 2019 · 6:00 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001226616
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 28, 2019 | M | 35,700 | $7.34 | A | 189,280 | D | |
| Common Stock | Feb 28, 2019 | M | 85,000 | $2.54 | A | 274,280 | D | |
| Common Stock | Feb 28, 2019 | M | 63,750 | $2.46 | A | 338,030 | D | |
| Common Stock | Feb 28, 2019 | M | 80,000 | $4.10 | A | 418,030 | D | |
| Common Stock | Feb 28, 2019 | M | 42,500 | $4.10 | A | 460,530 | D | |
| Common Stock | Feb 28, 2019 | M | 105,000 | $2.64 | A | 565,530 | D | |
| Common Stock | Feb 28, 2019 | M | 15,000 | $3.24 | A | 580,530 | D | |
| Common Stock | Feb 28, 2019 | M | 105,000 | $3.09 | A | 685,530 | D | |
| Common Stock | Feb 28, 2019 | M | 30,000 | $3.91 | A | 715,530 | D | |
| Common Stock | Feb 28, 2019 | M | 120,000 | $3.91 | A | 835,530 | D | |
| Common Stock | Feb 28, 2019 | M | 100,000 | $6.10 | A | 935,530 | D | |
| Common Stock | Feb 28, 2019 | M | 105,000 | $7.00 | A | 1,040,530 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $7.34 | Feb 28, 2019 | M | 35,700 | D | — | Jan 28, 2020 | Common Stock | 37,500 | 0 | D |
| Employee Stock Option (Right to Buy)F2 | $2.54 | Feb 28, 2019 | M | 85,000 | D | — | Jul 12, 2021 | Common Stock | 85,000 | 0 | D |
| Employee Stock Option (Right to Buy)F3 | $2.46 | Feb 28, 2019 | M | 63,750 | D | — | Aug 2, 2021 | Common Stock | 63,750 | 0 | D |
| Employee Stock Option (Right to Buy)F4 | $4.10 | Feb 28, 2019 | M | 80,000 | D | — | May 12, 2023 | Common Stock | 80,000 | 0 | D |
| Employee Stock Option (Right to Buy)F5 | $4.10 | Feb 28, 2019 | M | 42,500 | D | — | May 12, 2023 | Common Stock | 42,500 | 0 | D |
| Employee Stock Option (Right to Buy)F6 | $2.64 | Feb 28, 2019 | M | 105,000 | D | — | Dec 11, 2023 | Common Stock | 105,000 | 0 | D |
| Employee Stock Option (Right to Buy)F7 | $3.24 | Feb 28, 2019 | M | 15,000 | D | — | Dec 3, 2024 | Common Stock | 15,000 | 0 | D |
| Employee Stock Option (Right to Buy)F8 | $3.09 | Feb 28, 2019 | M | 105,000 | D | — | Jan 6, 2025 | Common Stock | 105,000 | 0 | D |
| Employee Stock Option (Right to Buy)F9 | $3.91 | Feb 28, 2019 | M | 30,000 | D | — | Jan 6, 2026 | Common Stock | 30,000 | 0 | D |
| Employee Stock Option (Right to Buy)F10 | $3.91 | Feb 28, 2019 | M | 120,000 | D | — | Jan 6, 2026 | Common Stock | 120,000 | 0 | D |
| Employee Stock Option (Right to Buy)F11 | $6.10 | Feb 28, 2019 | M | 100,000 | D | — | Jan 17, 2027 | Common Stock | 100,000 | 0 | D |
| Employee Stock Option (Right to Buy)F12 | $7.00 | Feb 28, 2019 | M | 105,000 | D | — | Jan 5, 2028 | Common Stock | 105,000 | 0 | D |
Explanation of responses
- F1The option vested over a period of 4 years in equal monthly installments from the 1/28/2010 date of grant and is now fully vested.
- F10The option was granted on 1/7/2016, was subject to vesting based on achievement of performance criteria and vested in full on 1/18/2017.
- F11The option was granted on 1/18/2017, was subject to vesting based on achievement of performance criteria and vested in full on 1/6/2018.
- F12The option was granted on 1/6/2018, was subject to vesting based on achievement of performance criteria and vested in full on 1/15/2019.
- F2The option vested over a period of 4 years in equal monthly installments from the 7/13/2011 date of grant and is now fully vested.
- F3The option was granted on 8/3/2011, was subject to vesting based on achievement of performance criteria and vested in full on 6/14/2012.
- F4The option was granted on 5/13/2013, was subject to vesting based on achievement of performance criteria and vested in full on 12/2/2013.
- F5The option vested over a period of 4 years in equal monthly installments from the 5/13/2013 date of grant and is now fully vested.
- F6The option was granted on 12/12/2013, was subject to vesting based on achievement of performance criteria and vested in full on 12/4/2014.
- F7The option vested over a period of 3 years in equal monthly installments from the 12/4/2014 date of grant and is now fully vested.
- F8The option was granted on 1/7/2015, was subject to vesting based on achievement of performance criteria and vested in full on 1/7/2016.
- F9The option vested over a period of 3 years in equal monthly installments from the 1/7/2016 date of grant and is now fully vested.